Advanced search
Publication Cover
Growth Factors Volume 20, 2002 - Issue 1
Submit an article Journal homepage
115
Views
78
CrossRef citations to date
0
Altmetric
Research Article

The EGF/ErbB Receptor Family and Apoptosis

Andrew J. Danielsen Tumor Biology Program, Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA
&
Nita J. Maihle Tumor Biology Program, Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA
Pages 1-15 | Published online: 11 Jul 2009

  • Abe, K. and Saito, H. (1992) "Protective effect of epidermal growth factor on glutamate neurotoxicity in cultured cerebellar neurons", Neuroscl. Res. 14(2), 117-123.
  • Abe, K., Takayanagi, M., et al., (1990a) "A comparison of neurotrophic effects of epidermal growth factor and basic fibroblast growth factor in primary cultured neurons from various regions of fetal rat brain", Jpn J. Pharmacol. 54(1), 45-51.
  • Abe, K., Takayanagi, M., et al. (1990b) "Effects of recombinant human basic fibroblast growth factor and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain", Jpn J. Pharmacol 53(2), 221-227.
  • Adamson, E.D. and Wiley, L.M. (1997) 'The EGFR gene family in embryonic cell activities", Curr. Top. Dev. Biol. 35, 71-120.
  • Alexi, T. and Hefti, F. (1993) 'Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture", Neumscience 55(4), 903-918.
  • Amundadottir, L.T., Nass, S.J., et al., (1996) "Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis", Oncogene 13(4), 757-765.
  • Armstrong, O.K., Kaufmann, S.H., et al., (1994) "Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells", Cancer Res. 54(20), 5280-5283.
  • Ashkenazi, A. and Dixit, V.M. (1998) "Death receptors: signaling and modulation", Science 281(5381), 1305-1308.
  • Bae, S.S., Choi, J.H., et al., (2001) "Proteolytic cleavage of epidermal growth factor receptor by caspases", FEES Lett. 491(1 -2), 16-20.
  • Baker, N.E. and Yu, S.Y. (2001) "The EGF receptor defines domains of cell cycle progression and survival to regulate cell number in the developing Drosophila eye", Cell 104(5), 699-708.
  • Baliga, R.R., Pimentai, D.R., et al., (1999) "NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK", Am. J. Physiol. 277(5 Pt 2), H2026-H2037.
  • Bates, S., Phillips, A.C., et al., (1998) "p14ARF links the tumour suppressors RB and p53", Nature 395(6698), 124-125.
  • Batzer, A.C., Rotin, D., et al., (1994) "Hierarchy of binding sites for Grb2 and She on the epidermal growth factor receptor", Mol. Cell Biol. 14(8), 5192-5201.
  • Belsches-Jablonski, A.P., Biscardi, J.S., et al., (2001) "Src family kinases and HER2 interactions in human breast cancer cell growth and survival", Oncogene 20(12), 1465-1475.
  • Bennett, M., Macdonald, K., et al., (1998) "Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis", Science 282(5387), 290-293.
  • Biswas, D.K., Cruz, A.P., et al., (2000) "Epidermal growth factor-induced nuclear factor kappa B activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells", Proc. Natl Acad. Sci. USA 97(15), 8542-8547.
  • Bogdan, S. and Klambt, C. (2001) "Epidermal growth factor receptor signaling", Curr. Biol 11(8), R292-R295.
  • Bonni, A., Brunet, A., et al., (1999) "Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms", Science 286(5443), 1358-1362.
  • Brison, D.R. and Schultz, R.M. (1997) "Apoptosis during mouse blastocyst formation: evidence for a role for survival factors including transforming growth factor alpha", Biol. Reprod. 56(5), 1088-1096.
  • Bromberg, J.F., Wrzeszczynska, M.H., et al., (1999) "Stat3 as an oncogene", Cell 98(3), 295-303.
  • Bruns, C.J., Solorzano, C.C., et al., (2000) "Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma", Cancer Res. 60(11), 2926-2935.
  • Canoll, P.D., Musacchio, J.M., et al., (1996) "GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors", Neuron 17(2), 229-243.
  • Cao, L., Yao, Y., et al., (2000) "Epidermal growth factor induces cell cycle arrest and apoptosis of squamous carcinoma cells through reduction of cell adhesion", J. Cell Biochem. 77(4), 569-583.
  • Carpenter, G. (2000) "The EGF receptor: a nexus for trafficking and signaling", Bioessays 22(8), 697-707.
  • Casper, D., Roboz, G.J., et al., (1994) "Epidermal growth factor and basic fibroblast growth factor have independent actions on mesencephalic dopamine neurons in culture", J. Neurochem. 62(6), 2166-2177.
  • Chin, Y.E., Kitagawa, M., et al., (1996) "Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1", Science 272(5262), 719-722.
  • Chin, Y.E., Kitagawa, M., et al., (1997) "Activation of the STAT Mol. Cell Biol. 17(9), 5328-5337.
  • Chinnaiyan, A.M., O'Rourke, K., et al., (1995) "FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis", Cell 81(4), 505-512.
  • Coles, H.S., Burne, J.F., et al., (1993) "Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor", Development 118(3), 777-784.
  • Cuello, M., Ettenberg, S.A., et al., (2001) "Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2", Cancer Res. 61(12), 4892-4900.
  • Daly, R.J. (1999) 'Take your partners, please--signal diversification by the erbB family of receptor tyrosine kinases", Growth Factors 16(4), 255-263.
  • Darcy, K.M., Wohlhueter, A.L., et al., (1999) "Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells", Eur. J. Cell Biol. 78(7), 511-523.
  • Darcy, K.M., Zangani, D., et al., (2000) "Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells", J. Histochem. Cytochem. 48(1), 63-80.
  • Dhein, I., Daniel, P.T., et al., (1992) "Induction of apoptosis by monoclonal anitbody and-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens", J. lmmunol. 149(10), 3166-3173.
  • Dominguez, M., Wasserman, J.D., et al., (1998) "Multiple functions of the EGF receptor in Drosophila eye development", Curr. Biol. 8(19), 1039-1048.
  • Earp, H.S., Dawson, T.L., et al., (1995) "Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research", Breast Cancer Res. Treat. 35(1), 115-132.
  • Evan, G. and Littlewood, T. (1998) "A matter of life and cell death", Science 281(5381), 1317-1322.
  • Fan, Z., Baselga, J., et al., (1993) "Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts", Cancer Res. 53(19), 4637-4642.
  • Fan, Z., Lu, Y., et al., (1995) "Prolonged induction of p21 Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition", J. Cell Biol 131(1), 235-242.
  • Fedi, P., Pierce, J.H., et al., (1994) "Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members", Mol. Cell Biol. 14(1), 492-500.
  • Fendly, B.M., Winget, M., et al., (1990) "Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product", Cancer Res. 50(5), 1550-1558.
  • Franke, T.F., Yang, S.I., et al., (1995) "The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase", Cell 81(5), 727-736.
  • Franke, T.F., Kaplan, D.R., et al., (1997) "Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate", Science 275(5300), 665-668.
  • Frisch, S.M. (1999) "Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis", Curr. Biol. 9(18), 1047-1049.
  • Frisch, S.M. and Francis, H. (1994) "Disruption of epithelial cell-matrix interactions induces apoptosis", J. Cell Biol. 124(4), 619-626.
  • Frisch, S.M., Vuori, K., et al., (1996) "Control of adhesion-dependent cell survival by focal adhesion kinase", J. Cell Biol. 134(3), 793-799.
  • Gardner, D.P. and Shimizu, N. (1994) "Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity", J. Cell Physiol 158(2), 245-255.
  • Gassmann, M., Casagranda, F., et al., (1995) "Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor", Nature 378(6555), 390-394.
  • Geier, A., Hemi, R., et al., (1993) "Epidermal growth factor and insulinlike growth factor-1 preserve cell viability in the absence of protein synthesis", In vitro Cell Dev. Biol 29A(3 Pt 1), 231-234.
  • Gibson, S., Tu, S., et al., (1999) "Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation", J. Biol. Chem. 274(25), 17612-17618.
  • Gomez-Pinilla, F., Knauer, D.I., et al., (1988) "Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization", Brain Res. 438(1-2), 385-390.
  • Goodlad, R.A. and Wright, N.A. (1996) "Epidermal growth factor (EGF)", Baillieres Clin. Castroenterol 10(1), 33-47.
  • Grandis, J.R., Draining, S.D., et al., (2000a) "Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo", Proc. Natl Acad. Sci USA 97(8), 4227-4232.
  • Grandis, J.R., Zeng, Q., et al., (2000b) "Epidermal growth factor receptor-mediated stat3 signaling blocks apoptosis in head and neck cancer", Laryngoscope 110(5 Pt 1), 868-874.
  • Gresik, E.W., Kashimata, M., et al., (1998) "The EGF system in fetal development", Eur. J. Morphol 36, 92-97.
  • Gross, A., Jockel, J., et al., (1998) "Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis", Embo J. 17(14), 3878-3885.
  • Gross, A., McDonnell, J.M., et al., (1999) "BCL-2 family members and the mitochondria in apoptosis", Genes Dev. 13(15), 1899-1911.
  • Guerra-Vladusic, F.K., Scott, G., et al., (1999) "Constitutive expression of Heregulin induces apoptosis in an erbB-2 overexpressing breast cancer cell line SKBr-3", Int. J. Oncol. 15(5), 883-892.
  • Gulli, L.F., Palmer, K.C., et al., (1996) "Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity", Cell Growth Differ. 7(2), 173-178.
  • Habib, A.A., Chatterjee, S., et al., (2001) "The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-mducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome", J. Biol. Chem. 276(12), 8865-8874.
  • Helmrath, M.A., Shin, C.E., et al., (1998) "The EGF? EGF-receptor axis modulates enterocyte apoptosis during intestinal adaptation", J. Surg. Res. 77(1), 17-22.
  • Hermeking, H. and Eick, D. (1994) "Mediation of c-Myc-induced apoptosis by p53", Science 265(5181), 2091-2093.
  • Hill, I.E., MacManus, J.P., et al., (1995) "DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat", Brain Res. 676(2), 398-403.
  • Hognason, T., Chatterjee, S., et al., (2001) "Epidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling", FEBS Lett. 491(1-2), 9-15.
  • Hsu, H., Shu, H.B., et al., (1996) "TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways", Cell 84(2), 299-308.
  • Huang, S.M. and Harari, P.M. (1999) "Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results", Invest. New Drugs 17(3), 259-269.
  • Huang, S.M., Bock, J.M., et al., (1999) "Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck", Cancer Res. 59(8), 1935-1940.
  • Hudziak, R.M., Lewis, G.D., et al., (1988) "Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells", Proc. Natl Acad. Sci. USA 85(14), 5102-5106.
  • Itoh, N. and Nagata, S. (1993) "A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen", J. Biol. Chem. 268(15), 10932-10937.
  • Jakus, J. and Yeudall, W.A. (1996) "Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells", Oncogene 12(11), 2369-2376.
  • lost, M., Class, R., et al., (1999) "A central role of Bcl-X(L) in the regulation of keratinocyte survival by autocrine EGFR ligands", J. Invest. Dermatol. 112(4), 443-449.
  • Jost, M., Huggett, T.M., et al., (2001) "Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway", J. Biol. Chem. 276(9), 6320-6326.
  • Kainulainen, V, Sundvall, M., et al., (2000) "A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis", J. Biol. Chem. 275(12), 8641-8649.
  • Kane, L.P., Shapiro, VS., et al., (1999) "Induction of NF-kappaB by the Akt/PKB kinase", Curr. Biol 9(11), 601-604.
  • Karnes, Jr., W.E., Weller, S.G., et al., (1998) "Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells", Castroentemlogy 114(5), 930-939.
  • Kaufmann, S.H. and Earnshaw, W.C. (2000) "Induction of apoptosis by cancer chemotherapy", Exp. Cell Res. 256(1), 42-49.
  • Kelliher, M.A., Grimm, S., et al., (1998) "The death domain kinase RIP mediates the TNF-induced NF-kappaB signal", Immunity 8(3), 297-303.
  • Kerr, J.F., Wyllie, A.H., et al., (1972) "Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics", Br. J. Cancer 26(4), 239-257.
  • Khwaja, A., Rodriguez-Viciana, P., et al., (1997) "Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway", Embo J. 16(10), 2783-2793.
  • Kinoshita, A., Yamada, K., et al., (1990) "Modification of anoxic neuronal injury by human recombinant epidermal growth factor and its possible mechanism", J. Neumsci. Res. 25(3), 324-330.
  • Klapper, LN., Kirschbaum, M.H., et al., (2000) "Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors", Adv. Cancer Res. 77, 25-79.
  • Komblum, H.I., Hussain, R.J., et al., (1997) "Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor alpha, in the rat brain", J. Comp. Neurol. 380(2), 243-261.
  • Kornblum, H.I., Hussain, R., et al., (1998) "Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor", J. Neurosci. Res. 53(6), 697-717.
  • Kornblum, H.I., Zurcher, S.D., et al., (1999) "Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system", Eur. J. Neurosci. 11(9), 3236-3246.
  • Kottke, T.J., Blajeski, A.L., et al., (1999) "Comparison of paclitaxel-5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis", J. Biol. Chem. 274(22), 15927-15936.
  • Krane, I.M. and Leder, P. (1996) "NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice", Oncogene 12(8), 1781-1788.
  • Kumar, R., Mandal, M., et al., (1996) "Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells", Clin. Cancer Res. 2(7), 1215-1219.
  • Lazar, L.M. and Blum, M. (1992) "Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-alpha mRNA in mouse brain by a quantitative nuclease protection assay", J. Neurosci. 12(5), 1688-1697.
  • Lee, K.F., Simon, H., et al., (1995) "Requirement for neuregulin receptor erbB2 in neural and cardiac development", Nature 378(6555), 394-398.
  • Leppa, S. and Bohmann, D. (1999) "Diverse functions of JNK signaling and c-Jun in stress response and apoptosis", Oncogene 18(45), 6158-6162.
  • Levy, R., Smith, S.D., et al., (2000) "Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor", Am. J. Physiol Cell Physiol. 278(5), C982-C988.
  • Li, P., Nijhawan, D., et al., (1997) "Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade", Cell 91(4), 479-489.
  • Li, Y, Bhuiyan, M., et al., (2000) "Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol", Clin. Cancer Res. 6(1), 223-229.
  • Li, Y., Tennekoon, G.I., et al., (2001) "Neuregulin signaling through a PI3 K/Akt/Bad pathway in Schwann cell survival", Mol. Cell Neurosci. 17(4), 761-767.
  • Lichtenstein, A., Berenson, I., et al., (1990) "Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes", Cancer Res. 50(22), 7364-7370.
  • Lin, X., Mu, Y., et al., (1998) "Molecular determinants of NF-kappaB-inducing kinase action", Mol. Cell Biol. 18(10), 5899-5907.
  • Linnik, M.D., Zobrist, R.H., et al., (1993) "Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats", Stroke 24(12), 2002-2008, discussion pp. 2008-2009.
  • Liu, B. and Fan, Z. (2001) "The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway", Oncogene 20(28), 3726-3734.
  • Liu, B., Fang, M., et al., (2000) "Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity", Br. J. Cancer 82(12), 1991-1999.
  • Liu, B., Fang, M., et al., (2001a) "Fibroblast growth factor and insulinlike growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody", Oncogene 20(15), 1913-1922.
  • Liu, B., Fang, M., et al., (2001b) "Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells", Br. J. Cancer 85(2), 303-311.
  • Loo, D.T., Bradford, S., et al., (1998) "Bcl-2 inhibits cell death of serumfree mouse embryo cells caused by epidermal growth factor deprivation", Cell Biol. Toxicol. 14(6), 375-382.
  • Maiese, K., Boniece, I., et al., (1993) "Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity", J. Neurosci. 13(7), 3034-3040.
  • Mandai, M., Adam, L., et al., (1998) "Nuclear targeting of Bax during apoptosis in human colorectal cancer cells", Oncogene 17(8), 999-1007.
  • Mehmet, H. (2001) "Stroke treatment enters the Fas lane", Cell Death Differ. 8(7), 659-661.
  • Mesner, Jr., P.W., Budihardjo, I, et al., (1997) "Chemotherapy-induced apoptosis", Acta. Pharmacol. 41, 461-499.
  • Meyer, D. and Birchmeier, C. (1995) "Multiple essential functions of neuregulin in development", Nature 378(6555), 386-390.
  • Miettinen, P.J., Huotari, M., et al., (2000) "Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors", Development 127(12), 2617-2627.
  • Miyashita, T. and Reed, J.C. (1995) "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene", Cell 80(2), 293-299.
  • Modjtahedi, H., Affleck, K., et al., (1998) "EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5", Int. J. Oncol. 13(2), 335-342.
  • Morrison, R.S., Komblum, H.I., et al., (1987) 'Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor", Science 238(4823), 72-75.
  • Musallam, L., Ethier, C., et al., (2001) "Role of EGF receptor tyrosine kinase activity in antiapoptotic effect of EGF on mouse hepatocytes", Am. J. Physiol Gastmintest. Liver Physiol. 280(6), G1360-G1369.
  • Muslin, A.I., Tanner, J.W., et al., (1996) "Interaction of 14-3-3 withCell 84(6), 889-897.
  • Muthuswamy, S.K. and Muller, W.J. (1995) "Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor", Oncogene 11(2), 271-279.
  • Mytilineou, C., Park, T.H., et al., (1992) "Epidermal growth factor-induced survival and proliferation of neuronal precursor cells from embryonic rat mesencephalon", Neurosci. Lett. 135(1), 62-66.
  • Nagane, M., Levitzki, A., et al., (1998) "Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bel-XL and caspase3-like proteases", Proc. Natl Acad. Sci. USA 95(10), 5724-5729.
  • Nass, S.J., Li, M., et al., (1996) "Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells", Biochem. Biophys. Res. Commun. 227(1), 248-256.
  • Nieto-Sampedro, M., Gomez-Pinilla, F., et al., (1988) "Epidermal growth factor receptor immunoreactivity in rat brain astrocytes. Response to injury", Neurosci. Lett. 91(3), 276-282.
  • Obata, H., Biro, S., et al., (1996) "NF-kappa B is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors", Biochem. Biophys. Res. Commun. 224(1), 27-32.
  • Olayioye, M.A., Neve, R.M, et al., (2000) "The ErbB signaling network: receptor heterodimerization in development and cancer", Embo J. 19(13), 3159-3167.
  • Oltvai, Z.N., Milliman, C.L., et al., (1993) "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death", Cell 74(4), 609-619.
  • Owen-Schaub, L.B., Zhang, W., et al., (1995) "Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression", Mol. Cell Biol. 15(6), 3032-3040.
  • Ozes, O.N., Mayo, L.D., et al., (1999) "NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase", Nature 401(6748), 82-85.
  • Pardee, A.B. (1974) "A restriction point for control of normal animal cell proliferation", Proc. Natl Acad. Sci. USA 71(4), 1286-1290.
  • Pauwels, P.J., van Assouw, H.P., et al., (1989) "Attenuation of neurotoxicity following anoxia or glutamate receptor activation in EGF- and hippocampal extract-treated neuronal cultures", Cell Signal 1(1), 45-54.
  • Pegram, M.D., Lipton, A., et al., (1998) "Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment", J. Clin. Oncol. 16(8), 2659-2671.
  • Pegram, M., Hsu, S., et al., (1999) "Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers", Oncogene 18(13), 2241-2251.
  • Pegram, M.D., Lopez, A., et al., (2000) "Trastuzumab and chemotherapeutics: drug interactions and synergies", Semin. Oncol. 27(6 Suppl 11), 21-25, discussion pp. 92-100.
  • Peles, H., Levy, R.B., et al., (1991) "Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma", Embo J. 10(8), 2077-2086.
  • Peng, H., Wen, T.C., et al., (1998) "Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries", J. Cereb. Blood Flow Metab. 18(4), 349-360.
  • Ferez, M. and Donato, N.J. (1996) "Activation of epidermal growth factor receptor tyrosine phosphorylation by tumor necrosis factor correlates with loss of cytotoxic activity", J. Interferon Cytokine Res. 16(4), 307-314.
  • Pianetti, S., Arsora, M., et al., (2001) "Her-2/neu overexpression induces NF-kappaB via a P13-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN", Oncogene 20(11), 1287-1299.
  • Pierce, J.H., Ruggiero, M., et al., (1988) "Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells", Science 239(4840), 628-631.
  • Prives, C. (1998) "Signaling to p53: breaking the MDM2-p53 circuit", Cell 95(1), 5-8.
  • Qin, X.Q., Livingston, D.M., et al., (1994) "Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis", Proc. Natl Acad. Sci. USA 91(23), 10918-10922.
  • Reinartz, J., Bechtel, M.J., et al., (1996) "Tumor necrosis factor-alpha-induced apoptosis in a human keratinocyte cell line (HaCaT) is counteracted by transforming growl factor-alpha", Exp. Cell. Res. 228(2), 334-340.
  • Ricci, A., Lanfrancone, L., et al., (1995) "Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase", Oncogene 11(8), 1519-1529.
  • Richter, M., Ebermann, R., et al., (1999) "Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling", Nutr. Cancer 34(1), 88-99.
  • Riese, II, D.I. and Stern, D.F. (1998) "Specificity within the EGF family/ErbB receptor family signaling network", Bioessays 20(1), 41-48.
  • Riese, II, D.I., van Raaij, T.M., et al., (1995) "The cellular response to neuregulins is governed by complex interactions of the erbB receptor family", Mol. Cell Biol. 15(10), 5770-5776.
  • Riethmacher, D., Sonnenberg-Riethmacher, E., et al., (1997) "Severe neuropathies in mice with targeted mutations in the ErbB3 receptor", Nature 389(6652), 725-730.
  • Rodeck, U., Jost, M., et al., (1997a) "Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor", Proc. Natl Acad. Sci. USA 94(10), 5067-5072.
  • Rodeck, U., Jost, M., et al., (1997b) "EGF-R dependent regulation of keratinocyte survival", J. Cell Sci. 110(Pt 2), 113-121.
  • Rodriguez-Viciana, P., Warne, P.H., et al., (1997) "Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras", Cell 89(3), 457-467.
  • Roh, H., Pippin, J., et al., (2000) "Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu", Cancer Res. 60(3), 560-565.
  • Rothman, S.M. and Olney, J.W. (1986) "Glutamate and the pathophysiology of hypoxic-ischemic brain damage", Ann. Neurol. 19(2), 105-111.
  • Salomon, D.S., Brandt, R., et al., (1995) "Epidermal growth factor-related peptides and their receptors in human malignancies", Crit. Rev. Oncol. Hematol. 19(3), 183-232.
  • Sandgren, E.P., Schroeder, J.A., et al., (1995) "Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice", Cancer Res. 55(17), 3915-3927.
  • Santoni-Rugiu, E., Jensen, M.R., et al., (1998) "Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha", Cancer Res. 58(1), 123-134.
  • Schaerli, P. and Jaggi, R. (1998) "EGF-induced programmed cell death of human mammary carcinoma MDA-MB-468 cells is preceded by activation AP-1", Cell Mol. Life Sci. 54(2), 129-138.
  • Schwarcz, R., Foster, A.C., et al., (1984) "Excitotoxic models for neurodegenerative disorders", Life Sci. 35(1), 19-32.
  • Seroogy, K.B., Lundgren, K.H., et al., (1993) "Cellular localization of transforming growth factor-alpha mRNA in rat forebrain", J. Neurochem. 60(5), 1777-1782.
  • Shen, K. and Novak, R.F. (1997) "Fas-signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells", Biochem. Biophys. Res. Commun. 230(1), 89-93.
  • Shen, M.M. and Schier, A.F. (2000) "The EGF-CFC gene family in vertebrate development", Trends Genet. 16(7), 303-309.
  • Sherr, C.J. and Roberts, J.M. (1999) "CDK inhibitors: positive and negative regulators of G1-phase progression", Genes Den 13(12), 1501-1512.
  • Sibilia, M., Steinbach, J.P., et al., (1998) "A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor", Embo J. 17(3), 719-731.
  • Sibilia, M., Fleischmann, A., et al., (2000) "The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development", Cell 102(2), 211-220.
  • Smida Rezgui, S., Honore, S., et al., (2000) "Up-regulation of alpha 2 beta 1 integrin cell-surface expression protects A431 cells from epidermal growth factor-induced apoptosis", Int. J. Cancer 87(3), 360-367.
  • Smith, D.R., Elnatan, J., et al., (1995) "Association of activated protooncogenes ras and myc in colorectal carcinomas", Ann. Acad. Med. Singapore 24(3), 393-398.
  • Soengas, M.S., Alarcon, R.M., et al., (1999) "Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition", Science 284(5411), 156-159.
  • Stern, L.E., Erwin, C.R., et al., (2000a) "Epidermal growth factor is critical for intestinal adaptation following small bowel resection", Microsc. Res. Tech. 51(2), 138-148.
  • Stern, L.E., Falcone, Jr., R.A., et al., (2000b) "Epidermal growth factor alters the bax:bcl-w ratio following massive small bowel resection", J. Surg. Res. 91(1), 38-42.
  • Stoll, S.W., Benedict, M., et al., (1998) "EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bel-XL", Oncogene 16(11), 1493-1499.
  • Strange, R., Li, F., et al., (1992) "Apoptotic cell death and tissue remodelling during mouse mammary gland involution", Development 115(1), 49-58.
  • Talhouk, R.S., Bissell, M.I., et al., (1992) "Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution", J. Cell Biol. 118(5), 1271-1282.
  • Tamm, I. and Kikuchi, T. (1990) "Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblasts", J. Cell Physiol. 143(3), 494-500.
  • Tao, W. and Levine, A.J. (1999) "P 19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2", Proc. Natl Acad Sci. USA 96(12), 6937-6941.
  • Tartaglia, L.A., Ayres, T.M., et al., (1993) "A novel domain within the 55 kd TNF receptor signals cell death", Cell 74(5), 845-853.
  • Tavare, J.M. and Holmes, C.H. (1989) "Differential expression of the receptors for epidermal growth factor and insulin in the developing human placenta", Cell Signal 1(1), 55-64.
  • Threadgill, D.W., Dlugosz, A.A., et al., (1995) 'Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype", Science 269(5221), 230-234.
  • Ting, A.T., Pimentel-Muinos, F.X., et al., (1996) "RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis", Embo J. 15(22), 6189-6196.
  • Tucker, M.S., Khan, I., et al., (1993) "Localization of immunoreactive epidermal growth factor receptor in neonatal and adult rat hippocampus", Brain Res. 631(1), 65-71.
  • Vaahtokari, A., Aberg, T., et al., (1996) "Apoptosis in the developing tooth: association with an embryonic signaling center and suppression by EGF and FGF-4", Development 122(1), 121-129.
  • Walker, F., Kato, A., et al., (1998) "Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation", Mol. Cell Biol. 18(12), 7192-7204.
  • Wang, C.Y., Mayo, M.W., et al., (1998) "NF-kappaB antiapoptosis: induction of TRAFl and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation", Science 281(5383), 1680-1683.
  • Wang, E., Marcotte, R., et al., (1999) "Signaling pathway forapoptosis: a racetrack for life or death", J. Cell Biochem. Suppl(32-33), 95-102.
  • Wen, Y, Hu, M.C., et al., (2000) "HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway", Cancer Res. 60(24), 6841-6845.
  • Werner, M.H., Nanney, L.B., et al., (1988) "Localization of immunoreactive epidermal growth factor receptors in human nervous system", J. Histochem. Cytochem. 36(1), 81-86.
  • Wu, X., Fan, Z., et al., (1995) "Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin", J. Clin. Invest. 95(4), 1897-1905.
  • Yang, E. and Korsmeyer, S.J. (1996) "Molecular thanatopsis: a discourse on the BCL2 family and cell death", Blood 88(2), 386-401.
  • Yarden, Y and Peles, E. (1991) "Biochemical analysis of the ligand for the neu oncogenic receptor", Biochemistry 30(14), 3543-3550.
  • Yarden, Y and Sliwkowski, M.X. (2001) "Untangling the ErbB signalling network", Nat. Rev. Mol. Cell Biol. 2(2), 127-137.
  • Yates, R.A., Nanney, L.B., et al., (1991) "Epidermal growth factor and related growth factors", Int. J. Dermatol. 30(10), 687-694.
  • Yeh, W.C., Shahinian, A., et al., (1997) "Early lethality, functional NE-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice", Immunity 7(5), 715-725.
  • Yeh, W.C., Pompa, J.L., et al., (1998) "FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis", Science 279(5358), 1954-1958.
  • Yin, C., Knudson, C.M., et al., (1997) "Bax suppresses tumorigenesis and stimulates apoptosis in vivo". Nature 385(6617), 637-640.
  • Yoshida, T., Satoh, M., et al., (1993) "Cytokines affecting survival and differentiation of an astrocyte progenitor cell line", Brain Res. Dev. Brain Res. 76(1), 147-150.
  • Yu, D., ling, T., et al., (1998a) "Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21 Cipl, which inhibits p34Cdc2 kinase", Mol. Cell 2(5), 581-591.
  • Yu, D., Liu, B., et al., (1998b) "Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol", Oncogene 16(16), 2087-2094.
  • Zelenaia, O., Schlag, B.D., et al., (2000) "Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB", Mol. Pharmacol. 57(4), 667-678.
  • Zhao, Y.Y, Sawyer, D.R., et al., (1998) "Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes", J. Biol. Chem. 273(17), 10261-10269.
  • Zhou, B.P., Hu, M.C., et al., (2000) "HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway", J. Biol. Chem. 275(11), 8027-8031.
  • Zindy, F., Eischen, C.M., et al., (1998) "Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization", Genes Dev. 12(15), 2424-2433.
  • Zong, W.X., Edelstein, L.C., et al., (1999) "The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis", Genes Dev. 13(4), 382-387.
  • Zou, H., Li, Y, et al., (1999) "An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9", J. Biol. Chem. 274(17), 11549-11556.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.